1. Home
  2. TNK vs NVCR Comparison

TNK vs NVCR Comparison

Compare TNK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$99.52

Market Cap

2.5B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.71

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNK
NVCR
Founded
2007
2000
Country
Bermuda
Switzerland
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
TNK
NVCR
Price
$99.52
$14.71
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
★ $96.80
$26.86
AVG Volume (30 Days)
354.5K
★ 1.4M
Earning Date
11-06-2026
10-29-2026
Dividend Yield
★ 1.05%
N/A
EPS Growth
N/A
★ 21.79
EPS
★ N/A
N/A
Revenue
N/A
★ $655,353,000.00
Revenue This Year
$14.17
$10.80
Revenue Next Year
N/A
$10.83
P/E Ratio
$8.05
★ N/A
Revenue Growth
N/A
★ 8.28
52 Week Low
$50.94
$9.82
52 Week High
$110.65
$21.45

Technical Indicators

Market Signals
Indicator
TNK
NVCR
Relative Strength Index (RSI) 53.35 44.38
Support Level $71.28 $13.33
Resistance Level $103.16 $15.22
Average True Range (ATR) 3.61 0.65
MACD -1.03 0.11
Stochastic Oscillator 37.85 40.70

Price Performance

Historical Comparison
TNK
NVCR

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: